These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23905406)

  • 1. [Management of opioid-induced nausea and vomiting].
    Hirakawa N
    Masui; 2013 Jul; 62(7):829-35. PubMed ID: 23905406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F; Ossipov MH
    Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
    Yamada T; Kanazawa Y; Aoki Y; Uchida E
    J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive therapy for nausea and vomiting in patients on opioid therapy for non-malignant pain in rheumatology].
    Scotto di Fazano C; Vergne P; Grilo RM; Bertin P; Bonnet C; Trèves R
    Therapie; 2002; 57(5):446-9. PubMed ID: 12611198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
    Mantovani G; Curreli L; Macciò A; Massa E; Massa D; Mulas C; Succu G; Contu P
    Anticancer Res; 1999; 19(4C):3495-502. PubMed ID: 10629642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic and clinical burden of opioid-induced nausea and vomiting.
    Nicholson BD
    Postgrad Med; 2017 Jan; 129(1):111-117. PubMed ID: 27690715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation.
    Coluzzi F; Rocco A; Mandatori I; Mattia C
    Curr Pharm Des; 2012; 18(37):6043-52. PubMed ID: 22747538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
    Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
    Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
    Tsukuura H; Ando Y; Gyawali B; Matsumoto M; Sugishita M; Honda K; Urakawa H; Maeda O; Hasegawa Y
    J Palliat Med; 2015 Nov; 18(11):977-80. PubMed ID: 26509390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid induced nausea and vomiting.
    Smith HS; Laufer A
    Eur J Pharmacol; 2014 Jan; 722():67-78. PubMed ID: 24157979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of opioid-related side effects.
    O'Mahony S; Coyle N; Payne R
    Oncology (Williston Park); 2001 Jan; 15(1):61-73, 77; discussion 77-8, 80-2. PubMed ID: 11271983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting.
    Sato J; Tanaka R; Ishikawa H; Suzuki T; Shino M
    Support Care Cancer; 2020 Mar; 28(3):1083-1088. PubMed ID: 31183560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of nausea and vomiting in pain medication for digestive cancer].
    Yamada T; Kanazawa Y; Uchida E; Yokoi K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1517-21. PubMed ID: 23064063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg.
    Zuniga JR; Papas AS; Daniels SE; Patrick K; Muse DD; Oreadi D; Giannakopoulos HE; Granquist EJ; Levin LM; Chou JC; Maibach H; Schachtel BP
    Pain Med; 2019 Dec; 20(12):2528-2538. PubMed ID: 30657996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidural buprenorphine and epidural droperidol for post-operative nausea or vomiting].
    Yokoyama K; Takahashi H; Toyoshima M; Tanaka K
    Masui; 1997 Jun; 46(6):798-802. PubMed ID: 9223884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
    Kanbayashi Y; Hosokawa T
    J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines.
    Gaertner J; Boehlke C; Kreye G; Fusi-Schmidhauser T; Mueller E; Roch C
    Support Care Cancer; 2024 Jun; 32(7):436. PubMed ID: 38879720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.